About [3-(4-fluorophenyl)-4-[(3S)-pyrrolidin-3-yl]oxyphenyl]-[(2S)-4-(3-fluoro-5-piperazin-1-ylbenzoyl)-2-propan-2-ylpiperazin-1-yl]methanone
[3-(4-fluorophenyl)-4-[(3S)-pyrrolidin-3-yl]oxyphenyl]-[(2S)-4-(3-fluoro-5-piperazin-1-ylbenzoyl)-2-propan-2-ylpiperazin-1-yl]methanone (PubChem CID 130471532) has the molecular formula C35H41F2N5O3
and a molecular weight of 617.74 g/mol. Its IUPAC name is [3-(4-fluorophenyl)-4-[(3S)-pyrrolidin-3-yl]oxyphenyl]-[(2S)-4-(3-fluoro-5-piperazin-1-ylbenzoyl)-2-propan-2-ylpiperazin-1-yl]methanone.
Molecular Properties
| Compound Name | [3-(4-fluorophenyl)-4-[(3S)-pyrrolidin-3-yl]oxyphenyl]-[(2S)-4-(3-fluoro-5-piperazin-1-ylbenzoyl)-2-propan-2-ylpiperazin-1-yl]methanone |
| PubChem CID | 130471532 |
| Molecular Formula | C35H41F2N5O3 |
| Molecular Weight | 617.74 g/mol |
| Exact Mass | 617.32 |
| IUPAC Name | [3-(4-fluorophenyl)-4-[(3S)-pyrrolidin-3-yl]oxyphenyl]-[(2S)-4-(3-fluoro-5-piperazin-1-ylbenzoyl)-2-propan-2-ylpiperazin-1-yl]methanone |
| SMILES | CC(C)[C@H]1CN(C(=O)c2cc(F)cc(N3CCNCC3)c2)CCN1C(=O)c1ccc(O[C@H]2CCNC2)c(-c2ccc(F)cc2)c1 |
| InChI | InChI=1S/C35H41F2N5O3/c1-23(2)32-22-41(34(43)26-17-28(37)20-29(18-26)40-13-11-38-12-14-40)15-16-42(32)35(44)25-5-8-33(45-30-9-10-39-21-30)31(19-25)24-3-6-27(36)7-4-24/h3-8,17-20,23,30,32,38-39H,9-16,21-22H2,1-2H3/t30-,32+/m0/s1 |
| InChIKey | BPYGSHQRDOMEBN-XDFJSJKPSA-N |
| XLogP | 4.40 |
| TPSA | 77.15 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 45 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 617.74 |
| LogP ≤ 5 | 4.40 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Analyze [3-(4-fluorophenyl)-4-[(3S)-pyrrolidin-3-yl]oxyphenyl]-[(2S)-4-(3-fluoro-5-piperazin-1-ylbenzoyl)-2-propan-2-ylpiperazin-1-yl]methanone with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of [3-(4-fluorophenyl)-4-[(3S)-pyrrolidin-3-yl]oxyphenyl]-[(2S)-4-(3-fluoro-5-piperazin-1-ylbenzoyl)-2-propan-2-ylpiperazin-1-yl]methanone?
The IUPAC name of [3-(4-fluorophenyl)-4-[(3S)-pyrrolidin-3-yl]oxyphenyl]-[(2S)-4-(3-fluoro-5-piperazin-1-ylbenzoyl)-2-propan-2-ylpiperazin-1-yl]methanone (CID 130471532) is [3-(4-fluorophenyl)-4-[(3S)-pyrrolidin-3-yl]oxyphenyl]-[(2S)-4-(3-fluoro-5-piperazin-1-ylbenzoyl)-2-propan-2-ylpiperazin-1-yl]methanone.
What is the SMILES notation for [3-(4-fluorophenyl)-4-[(3S)-pyrrolidin-3-yl]oxyphenyl]-[(2S)-4-(3-fluoro-5-piperazin-1-ylbenzoyl)-2-propan-2-ylpiperazin-1-yl]methanone?
The canonical SMILES for [3-(4-fluorophenyl)-4-[(3S)-pyrrolidin-3-yl]oxyphenyl]-[(2S)-4-(3-fluoro-5-piperazin-1-ylbenzoyl)-2-propan-2-ylpiperazin-1-yl]methanone is CC(C)[C@H]1CN(C(=O)c2cc(F)cc(N3CCNCC3)c2)CCN1C(=O)c1ccc(O[C@H]2CCNC2)c(-c2ccc(F)cc2)c1.
What is the InChIKey of [3-(4-fluorophenyl)-4-[(3S)-pyrrolidin-3-yl]oxyphenyl]-[(2S)-4-(3-fluoro-5-piperazin-1-ylbenzoyl)-2-propan-2-ylpiperazin-1-yl]methanone?
The InChIKey is BPYGSHQRDOMEBN-XDFJSJKPSA-N. The full InChI is InChI=1S/C35H41F2N5O3/c1-23(2)32-22-41(34(43)26-17-28(37)20-29(18-26)40-13-11-38-12-14-40)15-16-42(32)35(44)25-5-8-33(45-30-9-10-39-21-30)31(19-25)24-3-6-27(36)7-4-24/h3-8,17-20,23,30,32,38-39H,9-16,21-22H2,1-2H3/t30-,32+/m0/s1.
What are the key properties of [3-(4-fluorophenyl)-4-[(3S)-pyrrolidin-3-yl]oxyphenyl]-[(2S)-4-(3-fluoro-5-piperazin-1-ylbenzoyl)-2-propan-2-ylpiperazin-1-yl]methanone?
[3-(4-fluorophenyl)-4-[(3S)-pyrrolidin-3-yl]oxyphenyl]-[(2S)-4-(3-fluoro-5-piperazin-1-ylbenzoyl)-2-propan-2-ylpiperazin-1-yl]methanone has a molecular weight of 617.74 g/mol, XLogP of 4.40, 7 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for [3-(4-fluorophenyl)-4-[(3S)-pyrrolidin-3-yl]oxyphenyl]-[(2S)-4-(3-fluoro-5-piperazin-1-ylbenzoyl)-2-propan-2-ylpiperazin-1-yl]methanone is sourced from PubChem (CID 130471532), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).